July 14, 2021

VIA EDGAR  

Office of Life Sciences
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Jason Drory  

Re: AdaptHealth Corp.
Registration Statement on Form S-3
Filed June 29, 2021
File No. 333-257493

Dear Mr. Drory:

Reference is made to the Registration Statement on Form S-3 filed by AdaptHealth Corp. (the “Company”) with the U.S. Securities and Exchange Commission on June 29, 2021 (File No. 333-257493) (the “Registration Statement”).

The Company hereby requests the Registration Statement be made effective at 5:00 p.m., Eastern Time, on July 16, 2021 (the “Effectiveness Time”), or as soon as possible thereafter, in accordance with Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended.

If you have any questions related to this letter or if you require any additional information, please contact Michael Brandt or Danielle Scalzo of Willkie Farr & Gallagher LLP at (650) 887-8962 or (212) 728-8620, respectively. Please notify either of them when this request for acceleration of effectiveness of the Registration Statement has been granted.

July 14, 2021

Page 2

Very truly yours,
AdaptHealth Corp.
By:	/s/ Stephen Griggs
	Name: Stephen Griggs
	Title: Chief Executive Officer

Via E-mail:
cc:	Michael Brandt
	Danielle Scalzo
	Willkie Farr & Gallagher LLP